BACKGROUND: This study evaluated goal attainment for patients with a history of non-cardioembolic ischemic stroke (NCIS) or transient ischemic attack (TIA). METHODS: A cross-sectional study was conducted in patients aged 18 to 85 years with a history of validated NCIS or TIA. Data collected were demographics, comorbidities, blood pressure (BP), low-density lipoprotein cholesterol (LDL-C) values, and medications within 365 days and most proximal to December 31, 2010. Goal LDL-C and BP were defined as < 100 mg/dL and < 140/90 mm Hg, respectively. Differences in sex and age (< 65 vs ≥ 65 years) were evaluated. RESULTS: There were 1731 patients evaluated (mean age: 73.6 years; 58% women). Stroke type was NCIS in 51.9% and TIA in 48.1%. The LDL-C and BP were measured in 75.4% and 50.3% of patients, respectively. No difference in LDL-C screening rates existed for sex or age. Men and patients younger than age 65 years were significantly more likely to have BP measured. Overall, LDL-C and BP goals were attained by 48.9% and 43.3% of patients, respectively. Men and patients age 65 years or older were likelier than women and patients younger than age 65 years to attain LDL-C goals (p < 0.01). Men were also likelier than women to attain BP < 140/90 mm Hg (p < 0.01), but more patients younger than age 65 years vs older than age 65 years attained this goal (p < 0.01). Statins and antihypertensives were received by 51.9% and 46.9% of the patients, respectively. CONCLUSION: Although attaining guideline-recommended goals for LDL-C and BP may present challenges, future research should focus on innovative methods to help patients attain optimal treatment goals.
BACKGROUND: This study evaluated goal attainment for patients with a history of non-cardioembolic ischemic stroke (NCIS) or transient ischemic attack (TIA). METHODS: A cross-sectional study was conducted in patients aged 18 to 85 years with a history of validated NCIS or TIA. Data collected were demographics, comorbidities, blood pressure (BP), low-density lipoprotein cholesterol (LDL-C) values, and medications within 365 days and most proximal to December 31, 2010. Goal LDL-C and BP were defined as < 100 mg/dL and < 140/90 mm Hg, respectively. Differences in sex and age (< 65 vs ≥ 65 years) were evaluated. RESULTS: There were 1731 patients evaluated (mean age: 73.6 years; 58% women). Stroke type was NCIS in 51.9% and TIA in 48.1%. The LDL-C and BP were measured in 75.4% and 50.3% of patients, respectively. No difference in LDL-C screening rates existed for sex or age. Men and patients younger than age 65 years were significantly more likely to have BP measured. Overall, LDL-C and BP goals were attained by 48.9% and 43.3% of patients, respectively. Men and patients age 65 years or older were likelier than women and patients younger than age 65 years to attain LDL-C goals (p < 0.01). Men were also likelier than women to attain BP < 140/90 mm Hg (p < 0.01), but more patients younger than age 65 years vs older than age 65 years attained this goal (p < 0.01). Statins and antihypertensives were received by 51.9% and 46.9% of the patients, respectively. CONCLUSION: Although attaining guideline-recommended goals for LDL-C and BP may present challenges, future research should focus on innovative methods to help patients attain optimal treatment goals.
Authors: B Ovbiagele; J L Saver; H Bang; L E Chambless; A Nassief; J Minuk; J F Toole; J R Crouse Journal: Neurology Date: 2006-04-25 Impact factor: 9.910
Authors: Andrew T Yan; Raymond T Yan; Mary Tan; Daniel G Hackam; Kori L Leblanc; Heather Kertland; Jennifer L Tsang; Shahin Jaffer; Martin L Kates; Lawrence A Leiter; David H Fitchett; Anatoly Langer; Shaun G Goodman Journal: Am J Med Date: 2006-08 Impact factor: 4.965
Authors: Brian G Sandhoff; Leslie K Nies; Kari L Olson; James D Nash; Jon R Rasmussen; John A Merenich Journal: Am J Health Syst Pharm Date: 2007-01-01 Impact factor: 2.637
Authors: C A Sueta; M Chowdhury; S J Boccuzzi; S C Smith; C M Alexander; A Londhe; A Lulla; R J Simpson Journal: Am J Cardiol Date: 1999-05-01 Impact factor: 2.778
Authors: Jade W Wei; Ji-Guang Wang; Yining Huang; Ming Liu; Yangfeng Wu; Lawrence K S Wong; Yan Cheng; En Xu; Qidong Yang; Hisatomi Arima; Emma L Heeley; Craig S Anderson Journal: Stroke Date: 2010-03-11 Impact factor: 7.914
Authors: Leslie R Harrold; Darleen Lessard; Jorge Yarzebski; Jerry H Gurwitz; Joel M Gore; Robert J Goldberg Journal: Cardiology Date: 2003 Impact factor: 1.869
Authors: Ralph L Sacco; Robert Adams; Greg Albers; Mark J Alberts; Oscar Benavente; Karen Furie; Larry B Goldstein; Philip Gorelick; Jonathan Halperin; Robert Harbaugh; S Claiborne Johnston; Irene Katzan; Margaret Kelly-Hayes; Edgar J Kenton; Michael Marks; Lee H Schwamm; Thomas Tomsick Journal: Circulation Date: 2006-03-14 Impact factor: 29.690
Authors: Virginia J Howard; Rikki M Tanner; Aaron Anderson; Marguerite R Irvin; David A Calhoun; Daniel T Lackland; Suzanne Oparil; Paul Muntner Journal: Am J Med Date: 2015-03-10 Impact factor: 4.965